Gabelli & Co Investment Advisers’s Monogram Orthopaedics MGRM Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,700	Closed	-$145K	–	302
2025 Q3	$145K	Buy	+24,700	New	+$132K	0.02%	217

Gabelli & Co Investment Advisers's MGRM Position: Q4 2025 in Review

Gabelli & Co Investment Advisers sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 24,700 shares — an estimated $145K sold.

Gabelli & Co Investment Advisers first reported a position in MGRM in Q3 2025 and held it in 1 quarter. The position peaked at $145K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Gabelli & Co Investment Advisers reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 24,700 Monogram Orthopaedics shares in Q4 2025, an estimated $145K.
Gabelli & Co Investment Advisers first reported a position in Monogram Orthopaedics in Q3 2025 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Monogram Orthopaedics position peaked at $145K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2025, filed 5 Feb 2026.